Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 0 | 0 | 0 | 0 | 1 |
| Cost of Goods | N/A | N/A | N/A | 0 | 1 |
| Operating Expenses | 20,693 | 12,326 | 10,344 | 10,300 | 7,211 |
| Operating Income | -20,693 | -12,326 | -10,344 | -10,300 | -7,210 |
| Interest Expense | 0 | 0 | 0 | 10 | 1,900 |
| Other Income | 2,141 | 4 | 74 | 310 | 240 |
| Pre-tax Income | -18,552 | -12,322 | -10,270 | -10,000 | -8,870 |
| Net Income Continuous | -18,552 | -12,322 | -10,270 | -10,006 | -8,871 |
| Net Income | $-18,552 | $-12,322 | $-10,270 | $-10,000 | $-8,870 |
| EPS Basic Total Ops | -0.37 | -0.21 | -0.20 | -0.22 | -0.23 |
| EPS Basic Continuous Ops | -0.24 | -0.21 | -0.20 | -0.22 | -0.23 |
| EPS Diluted Total Ops | -0.37 | -0.21 | -0.20 | -0.22 | -0.23 |
| EPS Diluted Continuous Ops | -0.24 | -0.21 | -0.20 | -0.22 | -0.23 |
| EBITDA(a) | $-20,013 | $-11,646 | $-9,663 | $-9,540 | $-4,690 |